-
Je něco špatně v tomto záznamu ?
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis
O. Nyc, R. Tejkalova, Z. Kriz, F. Ruzicka, L. Kubicek, J. Matejkova, E. Kuijper, M. Krutova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2000-06-01 do 2018-12-31
Health & Medicine (ProQuest)
od 2000-06-01 do 2018-12-31
Public Health Database (ProQuest)
od 2000-06-01 do 2018-12-31
PubMed
27860531
DOI
10.1089/mdr.2016.0159
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- centra terciární péče MeSH
- ciprofloxacin farmakologie MeSH
- Clostridioides difficile klasifikace účinky léků genetika izolace a purifikace MeSH
- DNA bakterií genetika metabolismus MeSH
- DNA gyráza genetika metabolismus MeSH
- elektroforéza kapilární MeSH
- exprese genu MeSH
- fluorochinolony farmakologie MeSH
- klindamycin farmakologie MeSH
- klostridiové infekce farmakoterapie mikrobiologie MeSH
- lidé MeSH
- methyltransferasy genetika metabolismus MeSH
- metronidazol farmakologie MeSH
- mikrobiální testy citlivosti MeSH
- minisatelitní repetice MeSH
- mnohočetná bakteriální léková rezistence genetika MeSH
- multilokusová sekvenční typizace MeSH
- retrospektivní studie MeSH
- ribotypizace MeSH
- senioři MeSH
- substituce aminokyselin MeSH
- vankomycin farmakologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
AIM: To perform a retrospective analysis of the high occurrence of Clostridium difficile infection in the surgical department of a Czech tertiary care hospital and to identify weaknesses in C. difficile infection (CDI) prevention and control policies. METHODS: Clinical and epidemiological data on eleven CDI cases were collected. C. difficile isolates were characterized by capillary electrophoresis ribotyping, multilocus variable tandem repeat analysis (MLVA), gyrA gene fragment sequencing, and erm(B) fragment PCR amplification. Antibiotic susceptibility to metronidazole, vancomycin, ciprofloxacin, moxifloxacin, and clindamycin was tested. FINDINGS: Eleven CDI cases were caused by C. difficile PCR ribotype 001 strains. These strains revealed two different MLVA profiles with 11 tandem repeat differences. All isolates were susceptible to metronidazole and vancomycin and resistant to ciprofloxacin (MIC ≥32 mg/L), moxifloxacin (MIC ≥32 mg/L), and clindamycin (MIC ≥256 mg/L). All isolates revealed amino acid substitution Thr82Ile, in the GyrA and were erm(B) negative. CONCLUSION: Two fluoroquinolone and clindamycin-resistant C. difficile PCR ribotype 001 strain clusters occurred at one of the surgical departments of a tertiary care hospital. Ineffective decontamination with suboptimal concentration and time of exposure of sporicidal disinfectants may have resulted in C. difficile transmission.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010935
- 003
- CZ-PrNML
- 005
- 20181211085053.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/mdr.2016.0159 $2 doi
- 035 __
- $a (PubMed)27860531
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nyč, Otakar $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital , Praha, Czech Republic . $7 uk2007399535
- 245 10
- $a Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis / $c O. Nyc, R. Tejkalova, Z. Kriz, F. Ruzicka, L. Kubicek, J. Matejkova, E. Kuijper, M. Krutova,
- 520 9_
- $a AIM: To perform a retrospective analysis of the high occurrence of Clostridium difficile infection in the surgical department of a Czech tertiary care hospital and to identify weaknesses in C. difficile infection (CDI) prevention and control policies. METHODS: Clinical and epidemiological data on eleven CDI cases were collected. C. difficile isolates were characterized by capillary electrophoresis ribotyping, multilocus variable tandem repeat analysis (MLVA), gyrA gene fragment sequencing, and erm(B) fragment PCR amplification. Antibiotic susceptibility to metronidazole, vancomycin, ciprofloxacin, moxifloxacin, and clindamycin was tested. FINDINGS: Eleven CDI cases were caused by C. difficile PCR ribotype 001 strains. These strains revealed two different MLVA profiles with 11 tandem repeat differences. All isolates were susceptible to metronidazole and vancomycin and resistant to ciprofloxacin (MIC ≥32 mg/L), moxifloxacin (MIC ≥32 mg/L), and clindamycin (MIC ≥256 mg/L). All isolates revealed amino acid substitution Thr82Ile, in the GyrA and were erm(B) negative. CONCLUSION: Two fluoroquinolone and clindamycin-resistant C. difficile PCR ribotype 001 strain clusters occurred at one of the surgical departments of a tertiary care hospital. Ineffective decontamination with suboptimal concentration and time of exposure of sporicidal disinfectants may have resulted in C. difficile transmission.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a ciprofloxacin $x farmakologie $7 D002939
- 650 _2
- $a klindamycin $x farmakologie $7 D002981
- 650 _2
- $a klostridiové infekce $x farmakoterapie $x mikrobiologie $7 D003015
- 650 _2
- $a Clostridioides difficile $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D016360
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a DNA gyráza $x genetika $x metabolismus $7 D027081
- 650 _2
- $a DNA bakterií $x genetika $x metabolismus $7 D004269
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x genetika $7 D024901
- 650 _2
- $a elektroforéza kapilární $7 D019075
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fluorochinolony $x farmakologie $7 D024841
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methyltransferasy $x genetika $x metabolismus $7 D008780
- 650 _2
- $a metronidazol $x farmakologie $7 D008795
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a minisatelitní repetice $7 D018598
- 650 _2
- $a multilokusová sekvenční typizace $7 D058885
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a ribotypizace $7 D021521
- 650 _2
- $a centra terciární péče $7 D062606
- 650 _2
- $a vankomycin $x farmakologie $7 D014640
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tejkalová, Renata $u Department of Medical Microbiology, St. Anne's University Hospital, and Faculty of Medicine, Masaryk University , Brno, Czech Republic . $7 xx0071625
- 700 1_
- $a Kříž, Zdeněk $u 2nd Department of Surgery, St. Anne's University Hospital, and Faculty of Medicine, Masaryk University , Brno, Czech Republic . $7 _AN028836
- 700 1_
- $a Růžička, Filip $u 2 Department of Medical Microbiology, St. Anne's University Hospital, and Faculty of Medicine, Masaryk University , Brno, Czech Republic . $7 xx0071619
- 700 1_
- $a Kubíček, Luboš $u 2nd Department of Surgery, St. Anne's University Hospital, and Faculty of Medicine, Masaryk University , Brno, Czech Republic . $7 xx0248028
- 700 1_
- $a Matějková, Jana $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital , Praha, Czech Republic . $7 xx0209775
- 700 1_
- $a Kuijper, Ed $u Leiden University Medical Centre , Leiden, the Netherlands .
- 700 1_
- $a Krůtová, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital , Praha, Czech Republic; DNA Laboratory, Department of Pediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital , Praha, Czech Republic $7 xx0191653
- 773 0_
- $w MED00008749 $t Microbial drug resistance (Larchmont, N.Y.) $x 1931-8448 $g Roč. 23, č. 5 (2017), s. 609-615
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27860531 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20181211085217 $b ABA008
- 999 __
- $a ok $b bmc $g 1288420 $s 1007747
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 23 $c 5 $d 609-615 $e 20161118 $i 1931-8448 $m Microbial drug resistance $n Microb Drug Resist $x MED00008749
- LZP __
- $a Pubmed-20180404